Molecular Partners AG (SWX:MOLN)
Switzerland · Delayed Price · Currency is CHF 2.850
+0.100 (3.64%)
Oct 21, 2025, 5:31 PM CET
Molecular Partners AG Market Cap
Molecular Partners AG has a market cap or net worth of 106.57 million as of October 21, 2025. Its market cap has decreased by -21.12% in one year.
Market Cap
106.57M
Enterprise Value
-6.08M
Revenue
681.00K
Ranking
n/a
PE Ratio
n/a
Stock Price
2.85
Market Cap Chart
Since November 4, 2014, Molecular Partners AG's market cap has decreased from 426.07M to 106.57M, a decrease of -74.99%. That is a compound annual growth rate of -11.87%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 20, 2025 | 102.83M | -31.29% |
| Dec 30, 2024 | 149.66M | 32.42% |
| Dec 29, 2023 | 113.02M | -43.62% |
| Dec 30, 2022 | 200.48M | -65.16% |
| Dec 30, 2021 | 575.43M | -4.85% |
| Dec 30, 2020 | 604.78M | 60.28% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Roche Holding AG | 243.21B |
| Novartis AG | 201.75B |
| Lonza Group AG | 38.88B |
| Galderma Group AG | 32.50B |
| Alcon | 29.43B |
| Sandoz Group AG | 20.85B |
| Straumann Holding AG | 13.86B |
| Sonova Holding AG | 12.96B |